Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.India-based Orchid Chemicals & Pharmaceuticals has received approval from the FDA for its abbreviated new drug application for Cefpodoxime Proxetil tablets. The product is available in two dosage strengths, 100mg and 200mg.
Subscribe to our email newsletter
Cefpodoxime Proxetil is a third generation cephalosporin antibiotic which has a broad spectrum activity against organisms causing infectious diseases.
With limited generic competition in this product, Orchid hopes to garner a sizeable market share and revenues in the US market.